SOLV logo

Solventum (SOLV)

Profile

Full Name

Solventum Corporation

Ticker Symbol

SOLV

Exchange

NYSE

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

April 1, 2024

Indexes

S&P 500

Website

http://www.solventum.com

Employees

22000

Key Details

Price

$78.50(+0.32%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$8.25B(+0.70% YoY)

Annual EPS

$2.76(-64.57% YoY)

PE ratio

36.34

Next earnings date

Aug 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $78.50
    SOLV price is $78.50

    30-Day Relative Volume

    0.46
    SOLV 30-day relative volume is 0.46

    Price Performance

    Price Most recent change

    +0.32%
    SOLV price was up +0.32% on Jul 3, 2025

    Price YTD change

    +18.83%
    SOLV price is up +18.83% since January 1st

    Price 1-year change

    +54.38%
    SOLV price is up +54.38% year-on-year

    Price 3-year change

    -
    SOLV price 3-year change is unknown

    Price Range

    Price All-time high

    $85.92
    SOLV price is currently -8.64% below its historical high of $85.92

    Price 3-year low

    $47.16
    SOLV price is currently +66.45% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $13.58B
    SOLV market capitalization is $13.58 billion

    Market cap 3-year change

    -
    SOLV market capitalization 3-year change is unknown

    Market cap All-time high

    $14.62B
    SOLV market capitalization is currently -7.09% below its historical high of $14.62 billion

    Market cap sector rank

    94.19%
    SOLV market capitalization is higher than 94.19% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.18%
    SOLV shares outstanding is up +0.18% year-on-year

    Shares Outstanding 3-Year Change

    -
    SOLV shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.85
    SOLV beta is 0.85

    200-day SMA

    $71.73
    SOLV price is currently +9.43% above its 200-day simple moving average

    50-day SMA

    $72.26
    SOLV price is currently +8.64% above its 50-day simple moving average

    RSI

    69.02
    SOLV 14-day relative strength index is 69.02

    Volume

    0.46
    SOLV 30-day relative volume is 0.46

    ATR

    $1.52
    SOLV average true range is $1.52

    10-day Historical Volatility

    17.18%
    SOLV 10-day historical volatility is 17.18%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $8.25B
    SOLV annual revenue is $8.25 billion

    Revenue Analysts estimate

    $8.42B
    SOLV annual revenue is currently -2.01% lower than the consensus analysts' forecast

    Revenue 1-year change

    +0.7%
    SOLV annual revenue is up +0.7% year-on-year

    Revenue Sector rank

    93.32%
    SOLV annual revenue is higher than 93.32% of companies in Healthcare sector

    EPS

    EPS

    $2.76
    SOLV annual earnings per share is $2.76

    EPS Analysts estimate

    $5.56
    SOLV annual earnings per share is currently -50.36% lower than the consensus analysts' forecast

    EPS 1-year change

    -64.57%
    SOLV annual earnings per share is down -64.57% year-on-year

    EPS Sector rank

    93.42%
    SOLV annual earnings per share is higher than 93.42% of companies in Healthcare sector

    Profit

    Gross profit

    $4.59B
    SOLV annual gross profit is $4.59 billion

    Gross margin

    55.65%
    SOLV annual gross profit margin is 55.65%

    Operating profit

    $1.04B
    SOLV annual operating income is $1.04 billion

    Operating margin

    12.55%
    SOLV annual operating profit margin is 12.55%

    Net income

    $479.00M
    SOLV annual net profit is $479.00 million

    Net margin

    5.80%
    SOLV annual net profit margin is 5.80%

    Expenses

    Total expenses

    $7.22B
    SOLV annual total expenses is $7.22 billion

    Operating expenses

    $3.56B
    SOLV annual total operating expenses is $3.56 billion

    Cost of goods sold

    $3.66B
    SOLV annual cost of goods sold is $3.66 billion

    Selling, general & administrative expenses

    $2.78B
    SOLV annual SGA is $2.78 billion

    Depreciation and amortization

    $555.00M
    SOLV annual depreciation & amortization is $555.00 million

    Interest expense

    $367.00M
    SOLV annual interest expense is $367.00 million

    Income tax

    $127.00M
    SOLV annual income tax is $127.00 million

    EBIT & EBITDA

    EBIT

    $972.00M
    SOLV annual earnings before interest & taxes is $972.00 million

    EBITDA

    $1.53B
    SOLV annual EBITDA is $1.53 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $14.46B
    SOLV annual total assets is $14.46 billion

    Non current assets

    $11.21B
    SOLV annual long term assets is $11.21 billion

    Current assets

    $3.25B
    SOLV annual total current assets is $3.25 billion

    Cash and cash equivalents

    $762.00M
    SOLV annual cash & cash equivalents is $762.00 million

    Accounts receivable

    $1.04B
    SOLV annual accounts receivable is $1.04 billion

    Inventory

    $965.00M
    SOLV annual inventory is $965.00 million

    Liabilities

    Total liabilities

    $11.50B
    SOLV annual total liabilities is $11.50 billion

    Long term liabilities

    $8.79B
    SOLV annual total long term liabilities is $8.79 billion

    Current liabilities

    $2.70B
    SOLV annual total current liabilities is $2.70 billion

    Accounts payable

    $618.00M
    SOLV annual accounts payable is $618.00 million

    Debt

    Total debt

    $8.01B
    SOLV annual total debt is $8.01 billion

    Total debt 1-year change

    -3.53%
    SOLV annual total debt is down -3.53% year-on-year

    Long term debt

    $7.81B
    SOLV annual long term debt is $7.81 billion

    Short term debt

    $200.00M
    SOLV annual short term debt is $200.00 million

    Equity & Capital

    Shareholders equity

    $2.96B
    SOLV annual stockholders equity is $2.96 billion

    Book value

    $2.96B
    SOLV annual book value is $2.96 billion

    Retained earnings

    $242.00M
    SOLV annual retained earnings is $242.00 million

    Working capital

    $546.00M
    SOLV annual working capital is $546.00 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $1.19B
    SOLV annual cash flow from operations is $1.19 billion

    Cash from operations 1-year change

    -38.12%
    SOLV annual cash flow from operations is down -38.12% year-on-year

    Cash from investing

    -$380.00M
    SOLV annual cash flow from investing activities is -$380.00 million

    Cash from investing 1-year change

    -65.22%
    SOLV annual cash flow from investing activities is down -65.22% year-on-year

    Cash from financing

    -$240.00M
    SOLV annual cash flow from financing activities is -$240.00 million

    Cash from financing 1-year change

    +84.54%
    SOLV annual cash flow from financing activities is up +84.54% year-on-year

    CAPEX

    CAPEX

    $380.00M
    SOLV annual capital expenditures is $380.00 million

    CAPEX 1-year change

    +31.03%
    SOLV annual capital expenditures is up +31.03% year-on-year

    Free Cash Flow

    Free cash flow

    $805.00M
    SOLV annual free cash flow is $805.00 million

    Free cash flow 1-year change

    -50.46%
    SOLV annual free cash flow is down -50.46% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    55.65%
    SOLV annual gross profit margin is 55.65%

    Operating margin

    12.55%
    SOLV annual operating profit margin is 12.55%

    Net margin

    5.80%
    SOLV annual net profit margin is 5.80%

    ROA & ROE

    ROA

    3.37%
    SOLV annual return on assets is 3.37%

    ROE

    6.55%
    SOLV annual return on equity is 6.55%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    36.34
    SOLV price to earnings ratio is 36.34

    PE ratio Sector rank

    68.22%
    SOLV price to earnings ratio is higher than 68.22% of companies in Healthcare sector

    PB Ratio

    PB ratio

    4.16
    SOLV price to book ratio is 4.16

    PB ratio Sector rank

    76.8%
    SOLV price to book ratio is higher than 76.8% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.63
    SOLV price to sales ratio is 1.63

    PS ratio Sector rank

    34.7%
    SOLV price to sales ratio is higher than 34.7% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $20.96B
    SOLV enterprise value is $20.96 billion

    Enterprise value Sector rank

    94.63%
    SOLV enterprise value is higher than 94.63% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    16.24
    SOLV EV/EBITDA is 16.24

    EV/EBITDA Sector rank

    89.8%
    SOLV EV/EBITDA is higher than 89.8% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.20
    SOLV annual current ratio is 1.20

    Quick ratio

    0.84
    SOLV annual quick ratio is 0.84

    Leverage

    Debt to equity

    2.71
    SOLV annual debt to equity ratio is 2.71

    Interest coverage ratio

    2.65
    SOLV annual interest coverage ratio is 2.65

    Risk & Stability

    Piotroski F-Score

    5
    SOLV piotroski f-score is 5

    Altman Z-Score

    1.57
    SOLV altman z-score is 1.57

    Analyst ratings

    Recent major analysts updates

    May 19, 25 Piper Sandler
    Overweight
    May 9, 25 Piper Sandler
    Neutral
    Apr 30, 25 Piper Sandler
    Neutral
    Mar 5, 25 Morgan Stanley
    Equal-Weight
    Mar 3, 25 Mizuho
    Neutral
    Mar 3, 25 Goldman Sachs
    Sell
    Feb 28, 25 Wells Fargo
    Equal-Weight
    Feb 28, 25 Piper Sandler
    Neutral
    Feb 26, 25 B of A Securities
    Neutral
    Dec 4, 24 Mizuho
    Neutral

    Institutional Ownership

    Screeners with SOLV included

    Growing Shares Outstanding
    US stocks
    S&P 500 companies earnings calendar
    Stocks recommended to hold
    Best performing stocks last 3 months
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    Healthcare sector
    All stocks
    • What is the ticker symbol for Solventum?
    • Does Solventum pay dividends?
    • What sector is Solventum in?
    • What industry is Solventum in?
    • What country is Solventum based in?
    • When did Solventum go public?
    • Is Solventum in the S&P 500?
    • Is Solventum in the NASDAQ 100?
    • Is Solventum in the Dow Jones?
    • When was Solventum's last earnings report?
    • When does Solventum report earnings?
    • Should I buy Solventum stock now?

    What is the ticker symbol for Solventum?

    The ticker symbol for Solventum is NYSE:SOLV

    Does Solventum pay dividends?

    No, Solventum does not pay dividends

    What sector is Solventum in?

    Solventum is in the Healthcare sector

    What industry is Solventum in?

    Solventum is in the Medical Instruments & Supplies industry

    What country is Solventum based in?

    Solventum is headquartered in United States

    When did Solventum go public?

    Solventum's initial public offering (IPO) was on April 1, 2024

    Is Solventum in the S&P 500?

    Yes, Solventum is included in the S&P 500 index

    Is Solventum in the NASDAQ 100?

    No, Solventum is not included in the NASDAQ 100 index

    Is Solventum in the Dow Jones?

    No, Solventum is not included in the Dow Jones index

    When was Solventum's last earnings report?

    Solventum's most recent earnings report was on May 8, 2025

    When does Solventum report earnings?

    The next expected earnings date for Solventum is Aug 8, 2025

    Should I buy Solventum stock now?

    As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page